Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3416)
All Articles published online
|
Nov 28, 2007 (publication date) through Dec 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Diaz-Gonzalez JA, Arbea L, Aristu J. Rectal cancer treatment: Improving the picture. World J Gastroenterol 2007; 13(44): 5805-5812 [PMID: 17990346 DOI: 10.3748/wjg.v13.i44.5805] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i44/5805.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Leire Arbea, Rafael Martínez-Monge, Juan A. Díaz-González, Marta Moreno, Javier Rodríguez, Jose Luis Hernández, Jesús Javier Sola, Luis Isaac Ramos, Jose Carlos Subtil, Jorge Nuñez, Ana Chopitea, Mauricio Cambeiro, Miren Gaztañaga, Jesús García-Foncillas, Javier Aristu. Four-Week Neoadjuvant Intensity-Modulated Radiation Therapy With Concurrent Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer Patients: A Validation Phase II Trial. International Journal of Radiation Oncology*Biology*Physics 2012; 83(2): 587 doi: 10.1016/j.ijrobp.2011.06.2008
|
| 3 |
Esther Uña, Francisco López-Lara. Pilot Study of a Clinical Pathway Implementation in Rectal Cancer. Clinical Medicine Insights: Oncology 2010; 4 doi: 10.4137/CMO.S4651
|
| 4 |
Carolina De la Pinta, Margarita Martín, Asunción Hervás, Luis Cristian Perna, Eva Fernández-Lizarbe, Fernando López, Víctor Jose Duque, Sonsoles Sancho. Predictive factors for tumour response after the neoadjuvant-treatment of rectal adenocarcinoma. Journal of Coloproctology 2020; 40(02): 112 doi: 10.1016/j.jcol.2019.10.013
|
| 5 |
Ron Shapiro, Usama Ahmed Ali, Ian C. Lavery, Ravi P. Kiran. Endorectal ultrasound does not reliably identify patients with uT3 rectal cancer who can avoid neoadjuvant chemoradiotherapy. International Journal of Colorectal Disease 2013; 28(7): 993 doi: 10.1007/s00384-013-1645-5
|